What is Becton, Dickinson and Company's interventional — d&a?

Becton, Dickinson and Company (BDX) reported interventional — d&a of $192M in Q1 2026.

How has Becton, Dickinson and Company's interventional — d&a changed year-over-year?

Becton, Dickinson and Company's interventional — d&a decreased by 3.0% year-over-year, from $198M to $192M.

What is the long-term trend for Becton, Dickinson and Company's interventional — d&a?

Over 3 years (2021 to 2024), Becton, Dickinson and Company's interventional — d&a has grown at a 0.7% compound annual growth rate (CAGR), from $769M to $786M.

What does interventional — d&a mean?

The total non-cash expense for wear and tear on assets and the write-down of intangible assets within the Interventional segment.

Business Segments · D&A

Interventional — D&A

Becton, Dickinson and Company Interventional — D&A decreased by 2.5% to $192M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 3.0%, from $198M to $192M. Over 3 years (FY 2021 to FY 2024), Interventional — D&A shows relatively stable performance with a 0.7% CAGR.

Analysis

StatementSegment

CategoryEfficiency

SignalContext dependent

VolatilityStable

First reportedQ1 2016

Last reportedQ2 2026May 7, 2026

Rolls up toD&A

How to read this metric

An increase often signals significant capital investment or recent acquisitions, while a stable trend suggests consistent asset utilization.

Detailed definition

This metric captures the non-cash expenses related to the allocation of the cost of tangible and intangible assets over...

Peer comparison

Standard across all capital-intensive medical device manufacturers reporting segment-level depreciation and amortization.

Metric ID: bdx_segment_interventional_depreciation_and_amortization

Historical Data

18 periods

	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q1 '26	Q2 '26
Value	$192.25M	$192.25M	$197.25M	$197.25M	$197.25M	$197.25M	$199.75M	$199.75M	$199.75M	$199.75M	$196.5M	$196.5M	$196.5M	$196.5M	$200M	$198M	$197M	$192M
QoQ Change	—	+0.0%	+2.6%	+0.0%	+0.0%	+0.0%	+1.3%	+0.0%	+0.0%	+0.0%	-1.6%	+0.0%	+0.0%	+0.0%	+1.8%	-1.0%	-0.5%	-2.5%
YoY Change	—	—	—	—	+2.6%	+2.6%	+1.3%	+1.3%	+1.3%	+1.3%	-1.6%	-1.6%	-1.6%	-1.6%	+1.8%	+0.8%	-1.5%	-3.0%

Range$192M – $200M

CAGR-0.0%

Avg YoY Growth+0.1%

Median YoY Growth+1.0%

Current Streak3 quarters decline

Similar Metrics at Other Companies

DuPont de Nemours, Inc.DD View metric

DowDOW View metric

NordsonNDSN View metric

Zimmer Biomet HoldingsZBH View metric

BWX TechnologiesBWXT View metric

Zimmer Biomet HoldingsZBH View metric

Frequently Asked Questions

What is Becton, Dickinson and Company's interventional — d&a?: Becton, Dickinson and Company (BDX) reported interventional — d&a of $192M in Q1 2026.
How has Becton, Dickinson and Company's interventional — d&a changed year-over-year?: Becton, Dickinson and Company's interventional — d&a decreased by 3.0% year-over-year, from $198M to $192M.
What is the long-term trend for Becton, Dickinson and Company's interventional — d&a?: Over 3 years (2021 to 2024), Becton, Dickinson and Company's interventional — d&a has grown at a 0.7% compound annual growth rate (CAGR), from $769M to $786M.
What does interventional — d&a mean?: The total non-cash expense for wear and tear on assets and the write-down of intangible assets within the Interventional segment.